IDEAS home Printed from https://ideas.repec.org/p/fda/fdaeee/eee2026-23.html

Delaying retirement, reshaping exits, and the gender mortality gap: Evidence from the 2011 Spanish Pension Reform

Author

Listed:
  • Sergi Jiménez-Martín

Abstract

We estimate causal effects of the 2011 Spanish pension reform—which raised the normal retirement age (NRA) from 65 to 67, conditioning access on accumulated contribution years—on retirement timing, exit route, and premature mortality. Using data from the Muestra Continua de Vidas Laborales we find that the reform delayed retirement by about eight months on average for fully treated individuals belonging to the 1948-1957 cohorts, the cohorts observable in our data. Because the reform phases in gradually until the 1962 cohort—the first to face the fully phased-in rules, which then apply unchanged to all later cohorts—the total effect will be larger as more intensely affected cohorts complete their working lives. The dominant response is a reallocation away from retirement at and before age 65 toward retirement after 65, and is markedly larger for women, who are less likely to meet the long-career exemption. The reform raises premature mortality, significantly so for men; the implied gender differential widens the male mortality excess and narrows the female survival advantage, though sample-weighted gaps are sensitive to the large share of male controls.

Suggested Citation

  • Sergi Jiménez-Martín, 2026. "Delaying retirement, reshaping exits, and the gender mortality gap: Evidence from the 2011 Spanish Pension Reform," Studies on the Spanish Economy eee2026-23, FEDEA.
  • Handle: RePEc:fda:fdaeee:eee2026-23
    as

    Download full text from publisher

    File URL: https://documentos.fedea.net/pubs/eee/2026/eee2026-23.pdf
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:fda:fdaeee:eee2026-23. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Marta Fernández (email available below). General contact details of provider: https://www.fedea.net .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.